Treatment planning comparison between dynamic wave arc and volumetric modulated arc therapies for prostate-cancer treatment
Medical Dosimetry, ISSN: 0958-3947, Vol: 47, Issue: 1, Page: 48-53
2022
- 3Citations
- 3Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
The aim of this study was to compare the quality of dynamic wave arc (DWA) and coplanar volumetric modulated arc therapy (co-VMAT) plans for the treatment of localized prostate cancer. The planning target volume (PTV)-rectum, a section of the PTV comprising the PTV minus that of the rectum, received 78 Gy in 39 fractions as the mean dose to the PTV-rectum. The DWA and co-VMAT plans were generated for each patient using the RayStation treatment planning system for the Vero4DRT system. The PTV-rectum dose (D 95% : the percent dose irradiating 95% of the volume), homogeneity index (HI), conformity index (CI), as well as doses to the bladder wall, rectum wall (V 10–70 Gy: the percent volume receiving 10–70 Gy), and bilateral femoral heads of the DWA and co-VMAT plans were compared. The output monitor unit (MU) and delivery time obtained for each set of plans were also investigated. In terms of target coverage, the DWA plans provided an average D 95% of 75.5 Gy, which was comparable to the co-VMAT-plan D 95% of 75.2 Gy ( p < 0.05). The HI was significantly better with the DWA. As for the DWA plans, the bladder-wall volume receiving 10, 20, 30, and 40 Gy (V 10–40 Gy ) was significantly smaller than that of the co-VMAT plans, and the volume of the rectal wall receiving 10 Gy (V 10Gy ) was significantly larger than that of the co-VMAT plans. The DWA plans yielded a reduced dose to the bilateral femoral heads compared with the co-VMAT plans ( p < 0.05). The values of the CI and MU, and the delivery time exhibited no significant differences between the DWA and co-VMAT plans. The DWA plan is a feasible treatment option for prostate cancer radiotherapy.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0958394721000765; http://dx.doi.org/10.1016/j.meddos.2021.08.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85115030395&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34538693; https://linkinghub.elsevier.com/retrieve/pii/S0958394721000765; https://dx.doi.org/10.1016/j.meddos.2021.08.001
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know